Patents by Inventor Rao Movva

Rao Movva has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070270499
    Abstract: Disclosed is the identification of specific molecular targets and cellular pathways involved in the mechanism of action of 2-amino-2-propane-1,3-diols.
    Type: Application
    Filed: January 18, 2007
    Publication date: November 22, 2007
    Inventors: Carole Welsch, Rao Movva
  • Publication number: 20040214897
    Abstract: Disclosed is the identification of specific molecular targets and cellular pathways involved in the mechanism of action of 2-amino-2-propane-1;3-diols.
    Type: Application
    Filed: January 22, 2004
    Publication date: October 28, 2004
    Inventors: Carole Welsch, Rao Movva
  • Patent number: 6794186
    Abstract: The invention provides improvements in the field of animal models for testing effects of genes introduced into animal cells or tissue by adenoviral gene transfer. More particularly the invention provides a plasmid construct that expresses a porcine adenovirus receptor (pCAR) and transgenic animals that show expression of pCAR.
    Type: Grant
    Filed: July 5, 2001
    Date of Patent: September 21, 2004
    Assignee: Novartis AG
    Inventors: Thomas Bühler, Reto Andr as Gadient, Reinhard Korn, Rao Movva
  • Publication number: 20020059654
    Abstract: The invention provides improvements in the field of animal models for testing effects of genes introduced into animal cells or tissue by adenoviral gene transfer. More particularly the invention provides a plasmid construct that expresses a porcine adenovirus receptor (pCAR) and transgenic animals that show expression of pCAR.
    Type: Application
    Filed: July 5, 2001
    Publication date: May 16, 2002
    Inventors: Thomas Buhler, Reto Andreas Gadient, Reinhard Korn, Rao Movva
  • Patent number: 6165746
    Abstract: A process for the recombinant preparation in a bacterial host of the mature form of a mammalian protein or peptide of formula X-Pro-Z, which is subject to processing by endogenous bacterial aminopeptidases is provided. In the formula X-Pro-Z, X is a single N-terminal amino acid other than proline, and Z is the remaining sequence of amino acid residues of the protein or peptide. The process comprises inserting into a cell of the bacterial host an appropriate vector containing DNA coding for Met-Y-X-Pro-Z, in which Y is a natural amino acid that is specifically cleavable in vitro from X-Pro-Z by an aminopeptidases and that imparts resistance to in vivo processing by endogenous bacterial aminopeptidases. The cell is then induced to express the expression product Met-Y-X-Pro-Z which is then treated with an appropriate aminopeptidase to cleave off Met and Y.
    Type: Grant
    Filed: May 26, 1995
    Date of Patent: December 26, 2000
    Assignee: Novartis AG
    Inventors: Markus Heitzmann, Rao Movva, Paul Ramage